Showing results 1 to 20 of 33
next >
| Issue Date | Title | Author(s) |
| 2023-09 | A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-κB signaling in inflammatory lung diseases | Bhat, AA; Afzal, O; Agrawal, N; Thapa, R; Almalki, WH; Kazmi, I; Alzarea, SI; Altamimi, ASA; Kukreti, N; Chakraborty, A; Singh, SK; Dua, K; Gupta, G |
| 2022-06 | A narrative review on the biology of piezo1 with platelet-rich plasma in cardiac cell regeneration | Alharbi, KS; Almalki, WH; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Afzal, O; Alfawaz Altamimi, AS; Singh, SK; Dua, K; Kumar, G |
| 2023-12 | A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies | Thapa, R; Gupta, G; Bhat, AA; Almalki, WH; Alzarea, SI; Kazmi, I; Saleem, S; Khan, R; Altwaijry, N; Dureja, H; Singh, SK; Dua, K |
| 2022-08 | An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy | Alharbi, KS; Javed Shaikh, MA; Afzal, O; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Singh, SK; Dua, K; Gupta, G |
| - | Bioanalytical Method Development, Validation and Stability Assessment of Xanthohumol in Rat Plasma | Harish, V; Almalki, WH; Alshehri, A; Alzahrani, A; Alzarea, SI; Kazmi, I; Gulati, M; Tewari, D; Chellappan, DK; Gupta, G; Dua, K; Singh, SK |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| 2023-02 | Chitosan-based nano drug delivery system for lung cancer | Kazmi, I; Shaikh, MAJ; Afzal, O; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Al-Abbasi, FA; Pandey, M; Dureja, H; Singh, SK; Dua, K; Gupta, G |
| 2023-08 | Current progress in pharmacokinetic studies of vaccines: Impact of carrier, ADME and its modulation on immune responses | Jha, SK; Imran, M; Jha, LA; Hasan, N; Panthi, VK; Paudel, KR; Almalki, WH; Mohammed, Y; Kesharwani, P |
| 2022 | Current update on the protective effect of epicatechin in neurodegenerative diseases. | Thapa, R; Gupta, G; Dave, P; Singh, SK; Raizaday, A; Almalki, WH; Vyas, G; Singh, SK; Dua, K; Singh, Y |
| 2022-01-03 | CURRENT UPDATE ON THE PROTECTIVE EFFECT OF NARINGIN IN INFLAMMATORY LUNG DISEASES | Gupta, G; Almalki, WH; Kazmi, I; Fuloria, NK; Fuloria, S; Subramaniyan, V; Sekar, M; Singh, SK; Chellappan, DK; Dua, K |
| 2024-04-04 | Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics. | Thapa, R; Afzal, M; Goyal, A; Gupta, G; Bhat, AA; Almalki, WH; Kazmi, I; Alzarea, SI; Shahwan, M; Kukreti, N; Ali, H; Dureja, H; Kumar, P; Singh, TG; Kuppusamy, G; Singh, SK; Dua, K |
| 2022-01-01 | Exploring the mechanistic perspective of a new anti-tumor agent: Melatonin | Rohilla, S; Singh, M; Priya, S; Almalki, WH; Haniffa, SM; Subramaniyan, V; Fuloria, S; Fuloria, NK; Sekar, M; Singh, SK; Jha, NK; Chellappan, DK; Negi, P; Dua, K; Gupta, G |
| 2023-04 | Galangin as an inflammatory response modulator: An updated overview and therapeutic potential | Thapa, R; Afzal, O; Alfawaz Altamimi, AS; Goyal, A; Almalki, WH; Alzarea, SI; Kazmi, I; Jakhmola, V; Singh, SK; Dua, K; Gilhotra, R; Gupta, G |
| 2023-11-20 | Immunopathology of herpes simplex virus-associated neuroinflammation: Unveiling the mysteries. | Hussain, MS; Gupta, G; Samuel, VP; Almalki, WH; Kazmi, I; Alzarea, SI; Saleem, S; Khan, R; Altwaijry, N; Patel, S; Patel, A; Singh, SK; Dua, K |
| 2023-01 | Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease | Purohit, M; Gupta, G; Afzal, O; Altamimi, ASA; Alzarea, SI; Kazmi, I; Almalki, WH; Gulati, M; Kaur, IP; Singh, SK; Dua, K |
| 2022-12 | Neuropharmacological effect of risperidone: From chemistry to medicine | Bhat, AA; Gupta, G; Afzal, O; Kazmi, I; Al-Abbasi, FA; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Singh, SK; Dua, K |
| 2023-10-25 | New horizons in lung cancer management through ATR/CHK1 pathway modulation. | Thapa, R; Afzal, O; Bhat, AA; Goyal, A; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Kazmi, I; Singh, SK; Dua, K; Thangavelu, L; Gupta, G |
| 2022 | PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer. | Alharbi, KS; Shaikh, MAJ; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Imam, SS; Alshehri, S; Ghoneim, MM; Singh, SK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2022-12-13 | Polysaccharide-Based Nanomedicines Targeting Lung Cancer | Bhat, AA; Gupta, G; Alharbi, KS; Afzal, O; Altamimi, ASA; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Chellappan, DK; Singh, SK; MacLoughlin, R; Oliver, BG; Dua, K |
| 2023-08 | Probing the Links: Long Non-Coding RNAs and NF-κB Signalling in Atherosclerosis | Hussain, S; Afzal, O; Gupta, G; Altamimi, ASA; Almalki, WH; Alzarea, SI; Kazmi, I; Kukreti, N; Gupta, S; Sulakhiya, K; Singh, SK; Dua, K |
